Captivate Bio's RPMI 1640 Medium is is suitable for a variety of mammalian cells. This classical formulation is modified with L-glutamine and Phenol Red.

SB203580 is a selective ATP-competitive p38 MAPK inhibitor. Enhances the growth of mouse ES cells and enhances differentiation of cardiomyocytes from human ES cells.

SB431542 is a potent small molecule inhibitor of TGF-β signaling. Used for hESC neural differentiation and enhanced differentiation of PSCs into cardiomyocytes. Replaces SOX2 in reprogramming of fibroblasts into iPSCs.

SU5402 is a potent and selective inhibitor of VEGFR-2, FGFR-1, and PDGFRB.

Recombinant human TGF-beta 1 (TGF-β 1) protein containing 112 amino acids expressed in HEK293 cells for improved protein activity and proper post-translational modifications.

Thiazovivin is a novel ROCK inhibitor with IC50 of 0.5 μM in a cell-free assay, promotes hESC survival after single-cell dissociation. Improves the efficiency of fibroblast reprogramming and induction of iPSCs.

Thiazovivin (GMP-grade) is a novel ROCK inhibitor that promotes hESC survival after single-cell dissociation. Improves the efficiency of fibroblast reprogramming and induction of iPSCs. This small molecule is produced under GMP guidelines making it ideal for cell therapy research.

An integrated stress response (ISR) inhibitor that promotes survival of pluripotent stem cells in culture when used in combination with Chroman 1 and Emricasan small molecules in the CEPT cocktail¹.

Liothyronine sodium is an active form of thyroid hormone, also named Triiodothyronine Salt, this molecule selectively binds and activates β1 thyroid hormone receptor (TRβ1). Also regulates growth, metabolic activity, and hPSC differentiation.

XAV939 is a potent tankyrase (TNKS) inhibitor. Promotes cardiomyocyte differentiation in mesoderm progenitor cells. Also used in neuronal differentiation protocols.